SOCS1 and HIV infectious disease: Furthermore, immunization of HIV-infected patients with DCs loaded with inactivated HIV viruses led to a reduction in viral loads and an increase in CD4+ T cell numbers in the blood [72], suggesting that SOCS1 silencing could augment the effect of therapeutic HIV vaccines for the long-term control of HIV infection.